STOCKSCREENR

CYTO

NASDAQ

Altamira Therapeutics Ltd.

$0.30+0.30(+100.00%)Mkt Cap: $1.13M

Key Stats

Market Cap

$1.13M

P/E Ratio

0.16

EPS

$1.82

Dividend Yield

0.00%

52-Week Range

$0.30 — $0.42

Volume

724.29K

Avg Volume

244.03K

Beta

2.44

Price Alerts for CYTO

Get alerted when CYTO hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

0.16

Forward P/E

—

PEG Ratio

0.00

P/S (TTM)

0.00

P/B (TTM)

0.02

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-1.12%

ROA (TTM)

-0.84%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.05

Current Ratio

1.32

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.28%

EPS Growth (5Y)

+0.14%

Sales Growth (3Y)

+0.93%

Sales Growth (5Y)

+1.25%

EPS Est (This Year)

$-1.42

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$2.03

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

3.78M

Float

2.65M

Free Float %

70.25%

About

Sector

Healthcare

Industry

Biotechnology

Country

BM

Exchange

NASDAQ

IPO Date

2014-08-06

Employees

10

CEO

Thomas Meyer

Index Membership

—

Website

https://altamiratherapeutics.com

Altamira Therapeutics Ltd. (CYTO) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $1.13M, a P/E ratio of 0.16, CYTO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CYTO against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

MTNB

Matinas BioPharma Holdings, Inc.

$0.70

+7.47%

$3.88M

AIM

AIM ImmunoTech Inc.

$0.52

-0.64%

$1.75M

AZTR

Azitra, Inc.

$0.25

+0.45%

$2.66M

NFX.L

Nuformix plc

$0.17

+0.00%

$3.59M

BRTX

BioRestorative Therapies, Inc.

$0.23

+3.60%

$2.10M

Frequently Asked Questions

What is Altamira Therapeutics Ltd.'s P/E ratio?

Altamira Therapeutics Ltd. (CYTO) has a trailing twelve-month (TTM) P/E ratio of 0.16. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Altamira Therapeutics Ltd. pay a dividend?

No, Altamira Therapeutics Ltd. (CYTO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Altamira Therapeutics Ltd.'s market cap?

Altamira Therapeutics Ltd. (CYTO) has a market capitalization of $1.13 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.